Frazier Healthcare Partners has completed the acquisition of Altruix, a leading behavioral health-focused specialty pharmacy. Headquartered in Hunt Valley, Maryland, Altruix operates 17 pharmacies across the Mid-Atlantic region and serves more than 800 behavioral health providers and more than 32,000 patients per month. The company was previously backed by WindRose Health Investors, a New York-based private equity firm. Financial terms were not disclosed.
Altruix delivers high-touch clinical support, medication adherence programs, specialized packaging and access to complex therapies for patients with severe mental illness, substance use disorders and intellectual and developmental disabilities. Concurrent with the closing, Frazier Executive in Residence Randy Hyun has been appointed Chief Executive Officer. Hyun brings deep experience in pharmacy services, most recently as President of Evernorth Health System Services. Greg Ganse, Altruix’s former CEO, will remain as an investor and advisor.
Frazier has also appointed a seasoned board including Doug Present (formerly of Genoa Healthcare), John Rex (formerly of UnitedHealth Group), Eric Palmer (formerly of Evernorth), and Mark Peterson (formerly of Genoa Healthcare) to support Altruix’s next phase of growth. The transaction underscores continued private equity interest in differentiated behavioral health pharmacy platforms that improve outcomes for complex patient populations.
According to data captured in the LevinPro HC database, there have been eight Specialty Pharmacy acquisitions announced since the start of the year. Other acquirers in the space this year include GenieRx Holdings (acquired Omnicare), CareTria (acquired CaryHealth), Apotex (acquired Cumberland Pharmaceuticals), Pharma Fusion (acquired Columbia Pharmacy), Noom (acquired Tailor Made Compounding), Cigna (acquired CarepathRx) and CS One (acquired Partners Pharmacy Services). There were 23 Specialty Pharmacy transactions announced in 2025, and 28 announced in 2024.
